ROQ — Roquefort Therapeutics Share News
0.000.00%
FinancialsHighly SpeculativeMicro Cap
- £2.87m
- £2.87m
- £0.00m
RCS - Roquefort Theraptcs. - Investor Presentation
AnnouncementREG - Roquefort Theraptcs. - Price Monitoring Extension
AnnouncementREG - Roquefort Theraptcs. - Second Price Monitoring Extn
AnnouncementREG - Roquefort Theraptcs. - Proposed Acquisition of Oncogeni Limited & Placing
AnnouncementREG - Roquefort Theraptcs. - Notice of AGM - Correction
AnnouncementREG - Roquefort Theraptcs. - Pre-clinical Update
AnnouncementREG - Roquefort Theraptcs. - Notice of AGM
AnnouncementREG - Roquefort Theraptcs. - Annual Report & Financial Statements
AnnouncementREG - Roquefort Theraptcs. - Non-Executive Director Appointment
AnnouncementREG - Roquefort Theraptcs. - Board Appointment
AnnouncementREG - Roquefort Theraptcs. - Holding(s) in Company
AnnouncementRCS - Roquefort Theraptcs. - Investor Presentation
AnnouncementREG - Roquefort Theraptcs. - Patent Filed – New Drug Class Targeting Midkine
AnnouncementREG - Roquefort Theraptcs. - Holding(s) in Company
AnnouncementRCS - Roquefort Theraptcs. - Appointment of Strategic & Scientific Advisor
AnnouncementREG - Roquefort Theraptcs. - Holding(s) in Company
AnnouncementREG - Roquefort Theraptcs. - Holding(s) in Company
AnnouncementREG - Roquefort Theraptcs. - Director/PDMR Shareholding
AnnouncementREG - Roquefort Theraptcs. - Holding(s) in Company
Announcement